The human ST5 gene is expressed as 4.6, 3.1 and 2.8 kb transcripts encoding putative 126, 82 and 70 kDa proteins that function in the MAP kinase signaling pathway in transient expression assays. Expression of the 2.8 kb transcript correlates with reduced tumorigenicity in HeLa-®broblast hybrids, suggesting a role in tumor suppression. We now report the detection of ST5 proteins in cellular extracts, demonstrate speci®c expression of p70 in non-tumorigenic HeLa-®broblast hybrids, extend the correlation between p70 expression and cellular morphology to a wide variety of cell lines, and provide direct evidence that p70 can eect changes in cell growth and morphology. ST5 proteins were identi®ed in extracts of human, mouse and simian epithelial cells and ®broblasts, but were absent from lymphoid cells. Transfection of the 2.8 kb cDNA into a p70-negative mouse ®broblast line yielded stable transfectants with ā attened, less refractile morphology relative to controls. The p70 expressing clones had initial growth rates similar to those of control cells but their saturation density was reduced threefold, suggesting a restoration of contact-regulated growth. In conjunction with previous ®ndings, these results suggest that ST5 proteins participate directly in events aecting cytoskeletal organization and tumorigenicity.
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Keywords: ST5; signal transduction; cytoskeleton; contact-inhibition The ST5 gene products comprise three proteins that have been shown to function in signal transduction pathways in transient expression assays (Majidi et al., 1998) . The largest ST5 protein, p126, stimulates MAP kinase activation in response to EGF. Unique to this isoform are two [P-X-S/T-P] MAP kinase-phosphorylation target motifs (Davis, 1993) and two proline-rich regions characteristic of SH3-binding domains (Ren et al., 1993; Zhu and Shore, 1996) . This is potentially signi®cant since one of these domains binds preferentially to the SH3 domain of c-abl, and c-abl interacts synergistically with p126 to activate MAP kinase (Majidi et al., 1998) . A second isoform, p82, derived from an alternatively spliced mRNA species, lacks a 420 amino acid segment containing the SH3 binding motifs, and does not stimulate MAP kinase activity. The smallest of the three ST5 isoforms, p70, consists of the 609 C-terminal amino acids shared in common by all three gene products. This protein has homology to the rab3 class of small GTP-binding guanine-nucleotide exchange factors (Sudhof, 1997) and also to the MAPK Activating Death Domain protein, which is capable of self dimerization and dimerization with the type-I tumor necrosis factor receptor (Schievella et al., 1997) . In transient expression assays, p70 inhibits signaling through p126 (Majidi et al., 1998) .
The p70 protein may also play a role in tumor suppression. The 2.8 kb mRNA encoding p70 is driven by a promoter located within an intron of the ST5 gene (Lichy et al., 1996) . In a system of somatic cell hybrids used to detect tumor suppressor genes (Stanbridge and Wilkinson, 1980) , expression of the 2.8 kb message was found to be speci®c for non-tumorigenic HeLa/ ®broblast cell hybrids. These analyses indicated that the larger ST5 RNAs coding for 82 and 126 kDa proteins were present in both the nontumorigenic HeLa-®broblast hybrid cell line ESH5E and its tumorigenic segregant ESH5L, while expression of the 2.8 kb ST5 message was lost from the tumorigenic segregant (Lichy et al., 1992) .
In order to determine if this correlation extends to the protein level, detection of the native ST5 proteins in cell lines was performed. An antisera which would theoretically recognize all three of the predicted ST5 proteins was ®rst tested against the HeLa-®broblast cells, then used to screen a variety of other cell types for the proteins. Immunoreactivity, comigration with in vitro translated proteins, and correlation with the expression patterns observed at the RNA level were used as the identi®cation criteria. The IgG-fraction from this serum recognized all three in vitro synthesized proteins (Figure 1, lanes 1 ± 3) . More importantly, a putative p126 band was detected at similar levels in both ESH5L and ESH5E, but a p70 candidate was only detected in ESH5E (compare lane 4 with 5). The electrophoretic migration of both the 70 and the 126 kDa proteins was identical to that of the in vitro translated proteins. The absence of the 70 kDa band in ESH5L, which does not express the 2.8 kb mRNA, together with the comigration of the in vitro translated p70 and a band unique to ESH5E, supports its identi®cation as the ST5 p70 gene product. In addition, the 126 kDa but not the 70 kDa band reacted with an antibody which was anity puri®ed against a fusion protein bearing an amino acid sequence unique to p126 (data not shown). Although the crude antibody recognized additional proteins lying between p126 and p70, the detection of p82 was ambiguous, since none of the immunoreactive bands had electrophoretic identity with the in vitro synthesized protein. It is possible that p82 is not expressed in these cells or that the electrophoretic migration of the native protein is altered by posttranslational events. The observations that p70 was detected in the nontumorigenic ESH5E hybrid line but not in its tumorigenic segregant ESH5L, while p126 was found in both lines, are in agreement with the RNA analysis (Lichy et al., 1992) .
Similar analyses were conducted on a variety of cells of human, mouse and simian origin (Table 1) . Since the identi®cation of p82 was ambiguous it is not included in this summary. ST5-p126 was detected in all adherent cell lines examined regardless of origin, but was absent (at least 30-fold less abundant than in ESH5E) from a variety of lymphoid cell lines, including Raji, SudHL-5 and FTL-3. Since ST5 expression was also undetectable in lymphocytes at the RNA level, as shown below, this observation provided further con®rmation of the identity of the 126 kDa band detected by Western blot. This protein was also undetectable in extracts of the polymorphonuclear fraction of freshly drawn blood. Trace levels of p126 appeared to be present in the mononuclear blood cell fraction, suggesting that a subpopulation of circulating blood cells may express this protein. In agreement with the previously observed pattern of expression of the 2.8 kb transcript (Lichy et al., 1992) , the tumorigenic C33A and HeLa cell lines were devoid of p70 while primary keratinocytes, weakly tumorigenic Caski cells, and nontumorigenic HPV-16 immortalized Nco cells all had detectable p70.
The wide distribution of p126 in cultured cells prompted us to survey ST5 expression in normal human tissues. RNA levels were examined by probing a commercially available human tissue RNA blot with a 1750 nucleotide cDNA fragment common to the three ST5 RNAs (Figure 2 ). The negative controls included E. Coli and yeast RNA, as well as areas devoid of RNA. Expression was detected in all tissues except peripheral blood lymphocytes, with the highest levels found in uterus and testis. . Western blots were probed with anti-ST5 IgG raised against an amino acid sequence common to the three predicted proteins (aa's 494 ± 781 of p126), which was expressed as a tryp-E fusion protein. Cells were lysed in 10 mM Tris pH 7.9, 100 mM NaCl, 1 mM EDTA, 0.5% v/v Triton X-100, 0.05% w/v SDS while adhered to culture dishes, or were trypsinized from plates before washing and lysis. Protease inhibitors (100 mM PMSF, 0.078 TI units/ml aproptinin, 20 mg/ml leupeptin) and DTT (0.5 mM) were also included in most experiments. Proteins were separated on 12% SDS ± PAGE gels, blotted to PVDF, detected by immuno¯uorescence (Vistra Systems, Arlington Heights, IL, USA), and visualized on a Storm860 Fluorescence Imagen using Image Quant Software (Molecular Dynamics, Sunnyvale, CA, USA), with only linear adjustments to the sensitivity applied a=ambiguous results; (+)=at least 5% of that seen in ESH5E; p=possible, less than 5% that seen in ESH5E; (7)=none detected. Nco and 1321 (Dr R Schlegel, Georgetown University, DC); SudHL-5, J Cossman (Georgetown University, DC) by permission of A Epstein (Cancer Therapeutics Inc., LA); FTL-3 (Taubenberger et al., 1996) ; peripheral blood cells were freshly drawn and separated on Polymorphprep TM (Nycomed Pharma, Norway) The complete ST5-p70 sequence was excised from pcDNAIII/3.1 (Lichy et al., 1996) using BamHI and BglII, then ligated into pTRE digested with BamHI. This construct was transfected, along with pTK-Hyg, into NIH3T3-OFF lot #56552 (TET-OFF TM kit, Clontech 1996), by the calcium phosphate method (Ausubel, 1994) , and`NIH3T3-OFF/2.8' clones were selected on 200 mg/ml hygromycin. As a direct test of the downstream eects of p70, the human 2.8 kb cDNA was stably transfected into mouse cells. The commercially available NIH3T3-OFF line was designed to give inducible expression of proteins placed under the control of a tetracycline sensitive activator protein (Clontech, Palo Alta, CA, USA). This line contained a homogenous population of refractile cells which grew to a considerably greater density than that reported for NIH3T3 (Noda et al., 1989) and displayed some characteristics of the transformed phenotype, including a refractile morphology and high-density growth. In addition, they contained little if any p70 (Figure 3a, lane 1) , while NIH3T3 cells contained readily detectable p70 (lane 2). Upon transfection of the NIH3T3-OFF cells with the 2.8 kb cDNA, de®nitive eects on morphology and growth characteristics were observed.
Twenty-two clones transfected with the 2.8 kb cDNA cloned into the pTRE vector, along with ®ve control clones (transfected with the same plasmids without the cDNA insert) were isolated. Con¯uent plates of each clone were scored visually as having ā at or refractile phenotype (Table 2 ) and were analysed for p70 expression and inducibility by Western blot (Figure 3a , lane 4, typical clone #21). Seventeen out of 22 (77%) of the 2.8 kb transfectants were scored as ¯at, while ®ve had the refractile phenotype. All 17 of the¯at clones expressed p70, while only one of the ®ve clones with the parental phenotype expressed detectable p70. The ®ve clones isolated from the control transfection retained the parental morphology. None of the selected clones demonstrated inducible expression. Nevertheless, the result demonstrates a strong correlation between p70 expression and the¯at cellular morphology. The growth characteristics of three randomly chosen p70 expressing clones were compared to those of the parental cells and a randomly chosen control transfectant (Figure 3b) . The median saturation density determined from the combined analyses of the p70 expressors (open circles) was roughly threefold less than that of the parental NIH3T3-OFF cells (solid squares) or the control transfectant (solid triangles (Noda et al., 1989) . Despite the dierence in saturation density, the initial growth rate of the p70 expressing clones was only slightly slower than that of a b c d Figure 5 Actin organization in NIH3T3-OFF cells and ST5-p70 expressing transfectants. NIH3T3-OFF/Hyg #1 hygromycin resistant cells (a, c) or NIH3T3-OFF/2.8 #18 cells (b, d), were grown for at least 48 h after plating on glass slides (Nunc Inc., Naperville, IL, USA), then were formalin ®xed and stained with rhodamine-phalloidin (a, b) or were treated with 0.1 mg/ml colcemid (cat #234109, Calbiochem, La Jolla, CA, USA) for 1 h, then ®xed and stained (c, d). After ®xing in formaldehyde (3.7% ®nal conc., 10 min), cells were rinsed with PBS, permeablized in PBS plus 0.2% v/v Triton X-100 (10 min), incubated in rhodaminephalloidin (Molecular Probes, Eugene, OR, USA) 1 : 50 in PBS (2 h), and ®nally washed in PBS. Tubulin depolymerization was conducted before ®xation by placing cells on serum-free medium (16 ± 24 h) then replacing with colcemid medium for 1 h (Enomoto, 1996) the parental cells, regardless of plating density. However, this rate dropped within a few days of plating, suggesting contact dependent eects. The dramatic¯attening of the p70 expressing transfectants compared to the parental NIH3T3-OFF cells was evident by phase contrast microscopy ( Figure  4 ). The p70 expressing cells (Figure 4c ) were in extensive contact with neighboring cells within 48 h of replating, while the parental cells were not ( Figure  4a) . Furthermore, the p70 expressors stopped dividing at a relatively low cell density (Figure 3b and Figure  4d ) while parental cells continued to grow to high density after reaching con¯uence (Figure 4b ). In addition, rounded and highly refractile cells were always present in the parental cell cultures, but were absent from the p70 expressors. These observations distinguish the p70 expressing transfectants from the nonexpressors and support the possibility that p70 expression induces a return to contact-regulated growth, in agreement with the growth curves. Moreover, these dierences were highly stable, as cells were passaged over a 6 month period without spontaneous cellular transformation or loss of p70 expression. This contrasts to the behavior of NIH3T3 cells which undergo spontaneous transformation on prolonged passage in culture.
Changes in cell morphology are often associated with cytoskeletal reorganization. In addition, the maintenance of cell spreading involves a balance of forces provided by actin and tubulin (Bershadsky et al., 1996) . Therefore, an examination of actin distribution in the p70 expressors versus the parental cells, and a comparison of actin redistribution after tubulin depolymerization represents a qualitative measure of cytoskeletal organization. Cells were formalin-®xed and stained with rhodamine-labeled phalloidin, to visualize actin ( Figure 5 ). The control transfectants had an even distribution of actin throughout the cytoplasm, with the greatest intensity of staining near the nucleus (Figure 5a ). In contrast, only a small proportion of the actin was located near the nucleus in the p70 transfectants, while highly reinforced cortical actin ®laments were often visible at the periphery of the cells (Figure 5b ). Upon treatment with the tubulin depolymerizing drug colcemid, perinuclear staining was increased in the control cells, which took on a nearly spherical morphology (Figure 5c ). In contrast, the p70 expressors remained¯at and actin stress ®bers were reinforced upon tubulin depolymerization (Figure 5d) . Thus, the introduction of p70 was associated with distinct changes in actin distribution. This pattern of actin staining mimics that demonstrated for densityinhibited 3T3 cells (Kajstura and Bereiter-Hahn, 1993; Enomoto, 1996) , further suggesting that contact inhibited growth has been restored in these cells.
While these observations do not address the mechanism by which the restructuring occurred, they establish that p70 expression leads to a reorganization of cellular architecture.
It is unlikely that`nonspeci®c poisoning' can account for the observed eects of p70 expression, since the p70 expressors grew at similar initial rates to control cells and p70 accumulation varied over a range similar to that observed for endogenous p126 in the transfected cells. A more likely mechanism by which p70 might aect the cytoskeleton and the regulation of cell growth is through its participation in cellular signaling pathways. We have recently demonstrated that p126 exerts a positive eect on the Ras-MAP kinase signaling pathway (Majidi et al., 1998) . Improper Ras signaling through MAP-Kinase can lead to cellular transformation, including actin reorganization (Rodriguez-Viciana et al., 1997). Downstream events which are aected by actin disruption include the activation of c-abl (Zhu and Shore, 1996) induction of cyclin D1, the hyperphosphorylation of the Rb protein and G1-S transition (Bohmer et al., 1996) . A ®ne balance between signaling pathways is required to maintain normal regulation of cell cycle and contact-regulated growth (Bershadsky et al., 1996; Mainiero et al., 1997) . In conjunction with recent ®ndings that p70 blocks p126 mediated signal transduction from the EGF receptor to ERK2 (Majidi et al., 1998) , it is not surprising that p70 aects both actin organization and growth. Recently, the suppression of ERK signaling has been linked to alterations in cell morphology (Lu et al., 1998) . Thus, p70 may alter morphology or even contribute to reduced tumorigenicity through a cell signaling mechanism.
In summary, the results of this study establish that p70 expression can alter cytoskeletal organization, and convincingly restore contact-dependent growth to a spontaneously transformed mouse cell-line. Its detection in normal primary cells and nontumorigenic HeLa-®broblast hybrids, taken with its absence from highly tumorigenic lines, suggests that ST5 functions in normal cells, and may participate in determining tumorigenic potential.
